DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,033,000 | +46.2% | 54,487 | +0.1% | 0.07% | +38.8% |
| Q1 2021 | $1,391,000 | +12.5% | 54,429 | -3.0% | 0.05% | +16.7% |
| Q4 2020 | $1,236,000 | -25.0% | 56,129 | -38.7% | 0.04% | -22.2% |
| Q3 2020 | $1,648,000 | -31.8% | 91,626 | -3.7% | 0.05% | -18.2% |
| Q2 2020 | $2,417,000 | -3.6% | 95,129 | -30.3% | 0.07% | -12.0% |
| Q1 2020 | $2,506,000 | -22.8% | 136,473 | -7.4% | 0.08% | +1.4% |
| Q4 2019 | $3,247,000 | +308.9% | 147,458 | +166.7% | 0.07% | +311.1% |
| Q3 2019 | $794,000 | -9.7% | 55,300 | -0.9% | 0.02% | -10.0% |
| Q2 2019 | $879,000 | +6.4% | 55,800 | -1.1% | 0.02% | +17.6% |
| Q1 2019 | $826,000 | – | 56,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |